June 1, 2022

Collateral damage of COVID-19 on CV services

By: Judy Mathias

Editor's Note

This systematic review and meta-analysis led by researchers in the UK finds that across the world, cardiovascular (CV) services were severely disrupted, and as a result cardiac disease is expected to worsen, and repercussions will be felt for years to come.

This analysis spans 2 years (2020 to 2021) and includes 158 studies, covering 49 countries and 6 continents. During this time, when health systems around the world were under extreme pressure and people were afraid of catching COVID-19, those experiencing an acute cardiac event, such as myocardial infarction or heart failure, either stayed away or could not get admitted to a hospital. As a result, the number of people dying at home (up 7%) or in care homes (up 2%) from CV conditions increased.

Across all cardiovascular disease and geographies, there were fewer hospitalizations, diagnostic and interventional procedures, and outpatient consultations. However, in low-middle income countries, compared to high-income countries, the decline in myocardial infarction hospitalizations and revascularization procedures was more severe, and in-hospital mortality increased 17%.

The magnitude of decline in hospitalizations for cardiovascular diseases did not differ between the first and second waves of COVID-19.

This analysis brings to light the substantial impact COVID-19 has had and will continue to have in harming CV health globally, the researchers say.


Get OR Manager Updates

Sign Up Now
Latest Issue of OR Manager
June 2023
Video Spotlight
Live chat by BoldChat